Cold tuberculous abscess identified by FDG PET

Annals of Nuclear Medicine

Volumn 19, Issue 6, 2005, Pages 515-518

  Yago, Yuzo ^a   Yukihiro, Masashi ^a   Kuroki, Hirofumi ^a   Katsuragawa, Yuzo ^a   Kubota, Kazuo ^a  

^a NATIONAL CENTER FOR GLOBAL HEALTH AND MEDICINE   (Japan)

Author keywords

Abscess; FDG; Inflammation; PET; Tuberculosis

Indexed keywords

CA 19-9 ANTIGEN; CARCINOEMBRYONIC ANTIGEN; FLUORODEOXYGLUCOSE F 18;

ADULT; AGED; ARTICLE; CANCER RADIOTHERAPY; CASE REPORT; COLON CANCER; COMPUTER ASSISTED TOMOGRAPHY; CONTRAST ENHANCEMENT; DEVICE; DRUG UPTAKE; FEMALE; HUMAN; INFLAMMATION; LUNG CANCER; MYCOBACTERIUM TUBERCULOSIS; NUCLEAR MAGNETIC RESONANCE IMAGING; POSITRON EMISSION TOMOGRAPHY; PRIORITY JOURNAL; PSOAS ABSCESS; PYREXIA IDIOPATHICA; SPINE METASTASIS; TUBERCULOSIS; TUMOR BIOPSY;

EID: 27444441107     PISSN: 09147187     EISSN: None     Source Type: Journal    
DOI: 10.1007/BF02985581     Document Type: Article

References (16)

1. Kubota K. From tumor biology to clinical PET: a review of positron emission tomography (PET) in oncology. Ann Nucl Med 2001; 15: 471-486.
2. 18F]- fluorodeoxyglucose uptake in abdominal abscesses: a PET study. J Comput Assist Tomogr 1989; 13: 829-831.
3. Ichiya Y, Kuwabara Y, Sasaki M, Yoshida T, Akashi Y, Murayama S, et al. FDG PET in infectious lesions: the detection and assessment of lesion activity. Ann Nucl Med 1996; 10: 185-191.
4. Bleeker-Rovers CP, de Kleijn EMHA, Corstens FHM, et al. Clinical value of FDG PET in patients with fever of unknown origin and patients suspected of focal infection or inflammation. Eur J Nucl Med Mol Imaging 2004; 31: 29-37.
5. Bakheet SMB, Powe J, Ezzat A, Rostom A. F-18-FDG uptake in tuberculosis. Clin Nucl Med 1998; 23: 739-742.
6. Kubota R, Yamada S, Kubota K, et al. Intratumoral distribution of fluorine-18-fluorodeoxyglucose in vivo: high accumulation in macrophages and granulation tissue studied by microautoradiography. J Nucl Med 1992; 33: 1972-1980.
7. Yamada S, Kubota K, Kubota R, et al. High accumulation of fluorine-18-fluorodeoxyglucose in turpentine-induced inflammatory tissue. J Nucl Med 1995; 36: 1301-1306.
8. Sanabe N, Ikematsu Y, Nishiwaki Y, et al. Pancreatic tuberculosis. J Hepatobiliary Pancreat Surg 2002; 9: 515-518.
9. 18F]FDG in brain abscess: a PET study. J Comput Assist Tomogr 1990; 14: 486-487.
10. Knopp MV, Bischoff HG. Evaluation of pulmonary lesions with positron emission tomography. Radiology 1994; 34: 588-591.
11. Knight SB, Delbeke D, Stewart JR, Sandler MP. Evaluation of pulmonary lesions with FDG PET. Comparison of finding in patients with and without a history of prior malignancy. Chest 1996; 109: 982-988.
12. Yen RF, Chen ML, Liu FY, Ko SC, Chang YL, Chieng PU, et al. False-positive 2-[F-18]-fluoro-2-deoxy-D-glucose positron emission tomography studies for evaluation of focal pulmonary abnormalities. J Formos Med Assoc 1998; 97: 642-645.
13. Sugawara Y, Braun DK, Kison PV, et al. Rapid detection of human infections with fluorine-18 fluorodeoxyglucose and positron emission tomography: preliminary results. Eur J Nucl Med 1998; 25: 1238-1243.
14. Guengoer T, Engel-Bicik I, Eich G, et al. Diagnostic and therapeutic impact of whole body positron emission tomography using fluorine-18-fluoro-2- deoxy-D-glucose in children with chronic granulomatous disease. Arch Dis Child 2001; 85: 341-345.
15. 11C-Choline in lung cancer and pulmonary tuberculosis. Chest 2003; 124: 893-901.
16. Park CH, Lee MH, Oh CG. F-18 FDG positron emission tomographic imaging in bilateral iliopsoas abscesses. Clin Nucl Med 2002; 27: 680-681.